# Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery

> **NCT02372305** · PHASE4 · WITHDRAWN · sponsor: **University of Arkansas**

## Conditions studied

- Breast Neoplasm

## Interventions

- **BIOLOGICAL:** FlexHD
- **BIOLOGICAL:** Alloderm

## Key facts

- **NCT ID:** NCT02372305
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-03
- **Primary completion:** 2017-12-21
- **Final completion:** 2017-12-21
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI is no longer at institution. IRB closed study due to lack of response from PI
- **Last updated:** 2018-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02372305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02372305, "Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02372305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*